- Magnetic particle imaging, offering highly sensitive and quantitative imaging capabilities for a variety of biomedical applications, is becoming an increasingly vital component of modern medical diagnostics and research in both preclinical and clinical settings due to its enhanced image contrast, real-time tracking, and non-ionizing radiation
- The escalating demand for magnetic particle imaging (MPI) is primarily fueled by the widespread adoption of non-invasive diagnostic technologies, growing research into targeted drug delivery and cell tracking, and a rising preference for precise and quantitative imaging without the drawbacks of ionizing radiation
- North America dominates the magnetic particle imaging market, with the largest revenue share of 38.1% in 2024, characterized by a robust healthcare infrastructure, significant investment in research and development, and a strong presence of key industry players and academic institutions
- Asia-Pacific is expected to be the fastest-growing region in the magnetic particle imaging market during the forecast period, with a CAGR of 12.15%. This is due to increasing urbanization, rising disposable incomes, and a growing emphasis on early disease diagnosis and personalized medicine in countries such as China, Japan, and India
- MPI Scanner segment dominates the magnetic particle imaging market, with a market share of 55.7% in 2024, driven by the high capital investment required for these sophisticated imaging systems, which are the fundamental platforms for performing MPI
